טוען...
Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis
The pathogenesis of gastrointestinal tract involvement in SSc is not fully understood. However, gastrointestinal signs and symptoms are very common. Trials to test therapies, with rare exceptions, should be double-blind, randomized trials with either active therapy or placebo as comparators. Trial d...
שמור ב:
| הוצא לאור ב: | Rheumatology (Oxford) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5850471/ https://ncbi.nlm.nih.gov/pubmed/28992166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex195 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|